Epigenetic Immunologic Biomarkers in Allergic Rhinitis and CRSwNP: Methylation Signatures and Translational Prospects
Abstract
Allergic rhinitis (AR) and chronic rhinosinusitis with nasal polyps (CRSwNP) are distinct inflammatory disorders that may share type 2 immune features but differ in tissue pathology, clinical course, and therapeutic decision-making. This narrative review evaluates epigenetic immunologic biomarkers in the two diseases, with emphasis on deoxyribonucleic acid (DNA) methylation while also considering histone regulation and non-coding ribonucleic acid (RNA) networks. A structured literature search was used to organize evidence by disease, specimen, study design, and degree of clinical validation. Human AR studies provide signals in nasal epithelium, peripheral blood, and immune-cell subsets that relate to allergen exposure, symptom burden, immunoglobulin E (IgE)-associated biology, or treatment-associated changes. In CRSwNP, most epigenetic evidence comes from polyp or bulk sinonasal tissue and identifies methylation, chromatin, and microRNA patterns linked to inflammation and remodeling. These findings are biologically informative, but bulk-tissue signals can be strongly influenced by cell composition, and direct comparison across blood, nasal brushings, polyp tissue, and experimental models is not valid without qualification. No methylation- or RNA-based classifier has yet been prospectively validated to screen for future CRSwNP, replace current type 2 inflammatory markers, or select biologic therapy. Epigenetic enzyme inhibition and RNA delivery remain predominantly preclinical and face substantial challenges in target specificity, delivery, durability, and safety. The most credible path toward translation is therefore disease-specific and tissue-aware: standardized nasal sampling, cell-resolved profiling, independent multicenter validation, longitudinal designs, and demonstration of added value over established clinical biomarkers. Early risk prediction should currently be viewed as a research objective rather than a clinical application.
Keywords
References
- 1. Wang, J.; Zhou, Y.; Zhang, H.; et al. Pathogenesis of allergic diseases and implications for therapeutic interventions. Signal Transduct Target Ther. 2023, 8, 138. DOI: https://doi.org/10.1038/s41392-023-01344-4
- 2. Nur Husna, S.M.; Tan, H.T.; Md Shukri, N.; et al. Nasal Epithelial Barrier Integrity and Tight Junctions Disruption in Allergic Rhinitis: Overview and Pathogenic Insights. Front. Immunol. 2021, 12, 663626. DOI: https://doi.org/10.3389/fimmu.2021.663626
- 3. Toppila-Salmi, S.; Reitsma, S.; Hox, V.; et al. Endotyping in Chronic Rhinosinusitis—An EAACI Task Force Report. Allergy 2025, 80, 132–147. DOI: https://doi.org/10.1111/all.16418
- 4. Legaki, E.; Arsenis, C.; Taka, S.; et al. DNA methylation biomarkers in asthma and rhinitis: Are we there yet? Clin. Transl. Allergy 2022, 12, e12131. DOI: https://doi.org/10.1002/clt2.12131
- 5. Long, A.; Bunning, B.; Sampath, V.; et al. Epigenetics and the Environment in Airway Disease: Asthma and Allergic Rhinitis. In Epigenetics in Allergy and Autoimmunity; Springer: Singapore, 2020; pp. 153–181. DOI: https://doi.org/10.1007/978-981-15-3449-2_6
- 6. Hellings, P.W.; Steelant, B. Epithelial barriers in allergy and asthma. J. Allergy Clin. Immunol. 2020, 145, 1499–1509. DOI: https://doi.org/10.1016/j.jaci.2020.04.010
- 7. Sugita, K.; Soyka, M.B.; Wawrzyniak, P.; et al. Outside-in hypothesis revisited: The role of microbial, epithelial, and immune interactions. Ann. Allergy Asthma Immunol. 2020, 125, 517–527. DOI: https://doi.org/10.1016/j.anai.2020.05.016
- 8. Duan, S.; Jia, Z.; Zheng, L.; et al. Research advances on epigenetic modifications in dendritic cells in allergic rhinitis. Front. Immunol. 2025, 16, 1682821. DOI: https://doi.org/10.3389/fimmu.2025.1682821
- 9. Cardenas, A.; Sordillo, J.E.; Rifas-Shiman, S.L.; et al. The nasal methylome as a biomarker of asthma and airway inflammation in children. Nat. Commun. 2019, 10, 3095. DOI: https://doi.org/10.1038/s41467-019-11058-3
- 10. North, M.L.; Jones, M.J.; MacIsaac, J.L.; et al. Blood and nasal epigenetics correlate with allergic rhinitis symptom development in the environmental exposure unit. Allergy 2018, 73, 196–205. DOI: https://doi.org/10.1111/all.13263
- 11. Brar, T.; Marks, L.; Lal, D. Insights into the epigenetics of chronic rhinosinusitis with and without nasal polyps: A systematic review. Front. Allergy 2023, 4, 1165271. DOI: https://doi.org/10.3389/falgy.2023.1165271
- 12. Klimek, L.; Becker, S.; Haxel, B.; et al. Different immunological types of CRSwNP in the context of the new European EAACI nomenclature: Part 1: Hypersensitivity reactions of type IVa-c as a correlate to T1, T2, and T3 endotypes. HNO 2025, 73, 474–482. DOI: https://doi.org/10.1007/s00106-025-01600-9 (in German)
- 13. Zou, P.; Li, J.; Li, J.; et al. Inhibition of DNA Methyltransferase DNMT1 Reverses Th2 Response Polarisation and Alleviates Allergic Rhinitis. Clin. Exp. Pharmacol. Physiol. 2025, 52, e70015. DOI: https://doi.org/10.1111/1440-1681.70015
- 14. Li, H.; Lu, T.; Sun, W.; et al. Ten-Eleven Translocation (TET) Enzymes Modulate the Activation of Dendritic Cells in Allergic Rhinitis. Front. Immunol. 2019, 10, 2271. DOI: https://doi.org/10.3389/fimmu.2019.02271
- 15. Fan, W.; Liu, P.; Tan, L.; et al. Tet2 modulates M2 macrophage polarization via mRNA 5-methylcytosine in allergic rhinitis. Int. Immunopharmacol. 2024, 143, 113495. DOI: https://doi.org/10.1016/j.intimp.2024.113495
- 16. Yang, J.; Zhong, W.; Xue, K.; et al. Epigenetic changes: An emerging potential pharmacological target in allergic rhinitis. Int. Immunopharmacol. 2019, 71, 76–83. DOI: https://doi.org/10.1016/j.intimp.2019.03.004
- 17. Liu, T.; Sun, Y.; Bai, W. The Role of Epigenetics in the Chronic Sinusitis with Nasal Polyp. Curr. Allergy Asthma Rep. 2020, 21, 1. DOI: https://doi.org/10.1007/s11882-020-00976-8
- 18. Sun, X.; Liu, W.; Cui, Y.; et al. Epithelial histone deacetylase 7 (HDAC7) constitutes a negative feedback loop restraining interleukin (IL)-13-driven eosinophilic inflammation in chronic rhinosinusitis. Ann. Allergy Asthma Immunol. 2026, 136, 578–588.e3. DOI: https://doi.org/10.1016/j.anai.2026.01.013
- 19. Li, J.; Wang, M.; Yang, J.; et al. Mechanisms and Therapeutic Implications of EZH2 in Nasal Diseases. Clin. Rev. Allergy Immunol. 2025, 68, 46. DOI: https://doi.org/10.1007/s12016-025-09058-x
- 20. Zeng, R.; Wang, Y.; Song, X.; et al. The Role of EZH2 in Initiating Epigenetic Regulation of CRSwNP. J. Inflamm. Res. 2025, 18, 8607–8628. DOI: https://doi.org/10.2147/JIR.S525688
- 21. Li, H.; Li, J.; Lu, T.; et al. DZNep attenuates allergic airway inflammation in an ovalbumin-induced murine model. Mol. Immunol. 2021, 131, 60–67. DOI: https://doi.org/10.1016/j.molimm.2020.12.011
- 22. Li, S.; Cui, H.; Lu, H.; et al. Advances in noncoding RNA in children allergic rhinitis. Int. Forum Allergy Rhinol. 2024, 14, 1350–1362. DOI: https://doi.org/10.1002/alr.23393
- 23. Cheng, S.; Tang, Q.; Xie, S.; et al. The Role of Noncoding RNA in Airway Allergic Diseases through Regulation of T Cell Subsets. Mediators Inflamm. 2022, 2022, 6125698. DOI: https://doi.org/10.1155/2022/6125698
- 24. Tunçer, F.; Şahiner, Ü.M.; Ocak, M.; et al. Comparison of miRNA expression in patients with seasonal and perennial allergic rhinitis and non-atopic asthma. Turk. J. Pediatr. 2022, 64, 859–868. DOI: https://doi.org/10.24953/turkjped.2022.410
- 25. Yoo, Y.; Lee, J.S.; Park, Y.; et al. MicroRNA-4497 Is Downregulated in Pediatric Allergic Diseases and Suppresses Th2 Inflammation in an Animal Model. Int. Arch. Allergy Immunol. 2025, 186, 1176–1188. DOI: https://doi.org/10.1159/000545289
- 26. Gatsounia, A.; Schinas, G.; Danielides, G.; et al. Epigenetic Mechanisms in CRSwNP: The Role of MicroRNAs as Potential Biomarkers and Therapeutic Targets. Curr. Issues Mol. Biol. 2025, 47, 114. DOI: https://doi.org/10.3390/cimb47020114
- 27. Pasupat, D.; Chaiyasate, S.; Thonusin, C.; et al. Potential roles of microRNAs in chronic rhinosinusitis: From mechanistic insights to clinical studies. Eur. Arch. Otorhinolaryngol. 2026, 283, 4827–4852. DOI: https://doi.org/10.1007/s00405-026-10274-0
- 28. Lai, S.; Yu, L.; Sun, L.; et al. Integrated m6A methylome and transcriptome profiling of mRNAs and lncRNAs in nasal mucosal epithelial cells of allergic rhinitis patients undergoing allergen-specific immunotherapy. Clin. Epigenetics 2026, 18, 109. DOI: https://doi.org/10.1186/s13148-026-02128-7
- 29. Nestor, C.E.; Barrenäs, F.; Wang, H.; et al. DNA methylation changes separate allergic patients from healthy controls and may reflect altered CD4+ T-cell population structure. PLoS Genet. 2014, 10, e1004059. DOI: https://doi.org/10.1371/journal.pgen.1004059
- 30. Brar, T.; Baheti, S.; Marino, M.J.; et al. Genome-wide Epigenetic Study of Chronic Rhinosinusitis Tissues Reveals Dysregulated Inflammatory, Immunologic and Remodeling Pathways. Am. J. Rhinol. Allergy 2023, 37, 692–704. DOI: https://doi.org/10.1177/19458924231193526
- 31. Ordovas-Montanes, J.; Dwyer, D.F.; Nyquist, S.K.; et al. Allergic inflammatory memory in human respiratory epithelial progenitor cells. Nature 2018, 560, 649–654. DOI: https://doi.org/10.1038/s41586-018-0449-8
- 32. Rosário Filho, N.A.; Urrutia-Pereira, M.; D'Amato, G.; et al. Air pollution and indoor settings. World Allergy Organ. J. 2021, 14, 100499.
- 33. Kim, B.E.; Hui-Beckman, J.W.; Nevid, M.Z.; et al. Air pollutants contribute to epithelial barrier dysfunction and allergic diseases. Ann. Allergy Asthma Immunol. 2024, 132, 433–439. DOI: https://doi.org/10.1016/j.anai.2023.11.014
- 34. Yang, S.I. Particulate matter and childhood allergic diseases. Korean J. Pediatr. 2019, 62, 22–29. DOI: https://doi.org/10.3345/kjp.2018.07045
- 35. Liu, G.; Liu, S.X. Traffic-related air pollution and allergic rhinitis. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2018, 32, 153–156. DOI: https://doi.org/10.13201/j.issn.1001-1781.2018.02.018 (in Chinese)
- 36. Tingskov Pedersen, C.E.; Eliasen, A.U.; Ketzel, M.; et al. Prenatal exposure to ambient air pollution is associated with early life immune perturbations. J. Allergy Clin. Immunol. 2023, 151, 212–221. DOI: https://doi.org/10.1016/j.jaci.2022.08.020
- 37. Hew, K.M.; Walker, A.I.; Kohli, A.; et al. Childhood exposure to ambient polycyclic aromatic hydrocarbons is linked to epigenetic modifications and impaired systemic immunity in T cells. Clin. Exp. Allergy 2015, 45, 238–248. DOI: https://doi.org/10.1111/cea.12377
- 38. Morin, A.; McKennan, C.G.; Pedersen, C.T.; et al. Epigenetic landscape links upper airway microbiota in infancy with allergic rhinitis at 6 years of age. J. Allergy Clin. Immunol. 2020, 146, 1358–1366. DOI: https://doi.org/10.1016/j.jaci.2020.07.005
- 39. Ndika, J.; Karisola, P.; Lahti, V.; et al. Epigenetic Differences in Long Non-coding RNA Expression in Finnish and Russian Karelia Teenagers with Contrasting Risk of Allergy and Asthma. Front. Allergy 2022, 3, 878862. DOI: https://doi.org/10.3389/falgy.2022.878862
- 40. Klimek, L.; Wollenberg, B.; Guntinas-Lichius, O.; et al. Reasons for the development of allergies in children. HNO 2019, 67, 90–97. DOI: https://doi.org/10.1007/s00106-018-0595-1 (in German)
- 41. Rosa, M.J.; Lee, A.G.; Wright, R.J. Evidence establishing a link between prenatal and early-life stress and asthma development. Curr. Opin. Allergy Clin. Immunol. 2018, 18, 148–158. DOI: https://doi.org/10.1097/ACI.0000000000000421
- 42. Tan, L.; Ou, J.; Tao, Z.; et al. Neonatal Immune State Is Influenced by Maternal Allergic Rhinitis and Associated with Regulatory T cells. Allergy Asthma Immunol. Res. 2017, 9, 133–141. DOI: https://doi.org/10.4168/aair.2017.9.2.133
- 43. Tan, L.; Tao, Z.; Kong, Y.; et al. Reversible immune abnormality and regulatory T cells in offspring of Der p 1-exposed female mice. Asian Pac. J. Allergy Immunol. 2018, 36, 1–7.
- 44. Puosi, E.; Karlsson, H.; Lukkarinen, H.; et al. Paternal adverse childhood experiences are associated with a low risk of atopy in the offspring. Acta Paediatr. 2024, 113, 2438–2451. DOI: https://doi.org/10.1111/apa.17345
- 45. Xing, Y.; Wong, G.W. Environmental Influences and Allergic Diseases in the Asia-Pacific Region: What Will Happen in Next 30 Years?. Allergy Asthma Immunol. Res. 2022, 14, 21–39. DOI: https://doi.org/10.4168/aair.2022.14.1.21
- 46. Liang, L.; Willis-Owen, S.A.G.; Laprise, C.; et al. An epigenome-wide association study of total serum immunoglobulin E concentration. Nature 2015, 520, 670–674. DOI: https://doi.org/10.1038/nature14125
- 47. Watanabe, H.; Miyake, K.; Matsuoka, T.; et al. LPCAT2 Methylation, a Novel Biomarker for the Severity of Cedar Pollen Allergic Rhinitis in Japan. Am. J. Rhinol. Allergy 2021, 35, 631–639. DOI: https://doi.org/10.1177/1945892420983646
- 48. Bellinghausen, I.; Khatri, R.; Saloga, J. Current Strategies to Modulate Regulatory T Cell Activity in Allergic Inflammation. Front. Immunol. 2022, 13, 912529. DOI: https://doi.org/10.3389/fimmu.2022.912529
- 49. Li, J.; Sha, J.; Sun, L.; et al. Contribution of Regulatory T Cell Methylation Modifications to the Pathogenesis of Allergic Airway Diseases. J. Immunol. Res. 2021, 2021, 5590217. DOI: https://doi.org/10.1155/2021/5590217
- 50. Cheong, H.S.; Park, S.M.; Kim, M.O.; et al. Genome-wide methylation profile of nasal polyps: relation to aspirin hypersensitivity in asthmatics. Allergy 2011, 66, 637–644. DOI: https://doi.org/10.1111/j.1398-9995.2010.02514.x
- 51. Seiberling, K.A.; Church, C.A.; Herring, J.L.; et al. Epigenetics of chronic rhinosinusitis and the role of the eosinophil. Int. Forum Allergy Rhinol. 2012, 2, 80–84. DOI: https://doi.org/10.1002/alr.20090
- 52. Yonaga, T.; Ishii, H.; Yoshimura, K.; et al. Type 2 inflammation promotes distinct metabolic profiles in chronic rhinosinusitis with nasal polyps. Rhinology 2026, 64, 427–429. DOI: https://doi.org/10.4193/Rhin25.540
- 53. Kumar, N.; Brar, T.; Lal, D. Epigenetics in chronic rhinosinusitis. Curr. Opin. Otolaryngol. Head Neck Surg. 2026, 34, 58–65. DOI: https://doi.org/10.1097/MOO.0000000000001101
- 54. Yang, J.; Xue, J.; Mo, L.; et al. SpaCBA-OVA Liposome Reprograms Immune Tolerance to Ameliorate Allergic Rhinitis via DC-T Cell Crosstalk. Immunology 2026, 177, 725–735. DOI: https://doi.org/10.1111/imm.70078
- 55. Jakwerth, C.A.; Chaker, A.M.; Guerth, F.; et al. Sputum microRNA-screening reveals Prostaglandin EP3 receptor as selective target in allergen-specific immunotherapy. Clin. Exp. Allergy 2021, 51, 1577–1591. DOI: https://doi.org/10.1111/cea.14013
- 56. Raho, G.S. Probiotics in allergic disease: from adjunct supplement to immune-modifying strategy (2026 update). Curr. Opin. Allergy Clin. Immunol. 2026, 26, 313–320. DOI: https://doi.org/10.1097/ACI.0000000000001171
- 57. Zhang, X.; Zhang, Z.; Peng, Q.; et al. The Immunogenetic Landscape of Allergic Rhinitis: from Cellular Effectors to Gene Regulation and Targeted Therapies. Int. J. Biol. Sci. 2026, 22, 1322–1345. DOI: https://doi.org/10.7150/ijbs.126788
- 58. Moiseeva, Y.P.; Piskunov, G.Z. The development of a personalized approach in the treatment of chronic rhinosinusitis with nasal polyps. Vestn. Otorinolaringol. 2022, 87, 40–45. DOI: https://doi.org/10.17116/otorino20228703140 (in Russian)
- 59. Sultana, H.; Solomon, A.D.; Wani, A.K.; et al. Epigenetic dysregulation in pancreatic cancer: emerging biomarkers and clinical applications. Front. Epigenet. Epigenomics 2025, 3, 1723159. DOI: https://doi.org/10.3389/freae.2025.1723159
- 60. Sultana, H.; Mohanty, S.; Solomon, A.D.; et al. AI in Genomics: From Variant Calling to Multi-Omics Integration. BioEssays 2026, 48, e70160. DOI: https://doi.org/10.1002/bies.70160